
	Three Months Ended September 30,				Nine Months Ended September 30,
	2026		2025		2026		2025
Depreciation expense	$	110	$	103	$	328	$	308
Amortization expense	37		39		112		117
Depreciation and amortization expense	$	147	$	142	$	440	$	425

Interest expense	$	(67)	$	(69)	$	(200)	$	(210)
Interest income	6		3		13		10
Interest expense, net	$	(61)	$	(66)	$	(187)	$	(200)

Interest paid	$	22	$	22	$	151	$	167
Income taxes paid	$	38	$	2	$	142	$	112

Deferred income tax liabilities	$	512	$	378	$	512	$	378
Trade accounts payable	$	417	$	353	$	417	$	353

Accounts payable associated with capital expenditures	$	54	$	40	$	54	$	40

Dividends payable	$	95	$	91	$	95	$	91










Leases:




Leased assets obtained in exchange for new operating lease liabilities	$	40	$	44	$	141	$	140

During the nine months ended September 30, 2026 and 2025, other financing activities, net in the Company's consolidated statement of cash flows included changes in bank overdrafts, which are generally settled in cash in the short term, of $(163) million and $(61) million, respectively.

During the nine months ended September 30, 2025, the Company received $46 million from a payroll tax credit under the Coronavirus Aid, Relief, and Economic Security Act associated with the retention of employees. Such amount is recorded in other operating expense, net in the Company's consolidated statement of operations.